Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 1.09 Billion | USD 7.15 Billion | 20.7% | 2024 |
The global medical exoskeleton market size was worth around USD 1.09 Billion in 2024 and is predicted to grow to around USD 7.15 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 20.7% between 2025 and 2034.
The report analyzes the global medical exoskeleton market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the medical exoskeleton industry.
Exoskeletons are used to increase a person's physical strength by helping limb movements with additional strength. Medical exoskeletons help persons who are physically disabled, such as those who have had a spinal cord injury, have a neurological condition, is paralyzed, or are elderly. Physiotherapy and rehabilitation institutes employ some medical human exoskeletons for treatment of the lower and upper extremities. The increase in the number of orthopaedic operations, the rise in the geriatric population, and the rising rates of road accidents are all contributing to the worldwide medical exoskeleton market's growth. However, the exorbitant expense of the product, as well as regulatory issues, is the main roadblocks to commercial expansion. As a result, the limbs have increased mobility, strength, and endurance as a result of this construction.
The global demand for effective rehabilitation procedures, including the use of cutting-edge technology and goods, is increasing. In all main regions, this is seen as a positive indicator of the medical exoskeleton market's growth. As a result, you might have an impact on market dynamics during the forecast period. Furthermore, the increasing number of persons with physical limitations will have a significant impact on the medical exoskeleton market's growth. Additionally, rising geriatric population and increased access to medical exoskeleton insurance coverage in various nations are major factors boosting the growth of the medical exoskeleton market. Furthermore, an increase in the number of traffic accidents, serious injuries, and strokes will boost the market's growth rate. Increased spending on healthcare infrastructure is one of the primary industry drivers that will propel the medical exoskeleton market forward.
In the last decade, production and development of different robotic technologies that amplify human strength have been one of the major trends in the robotics sector. Many industry players have introduced technologically advanced human exoskeletons, which have many industrial and medical applications. Human exoskeletons are also called wearable robots provide a skeleton outside a person’s body that acts as a body extension. These extensions help humans to produce more power like a machine. These exoskeletons are gaining popularity due to their ability to support humans in dynamic conditions. They can assist a disabled person in carrying out different activities. These devices could reduce back injuries and other mishaps in industries, where injuries are a common thing. Various human exoskeleton prototypes and models are being used in physical therapy and are being deployed in several rehabilitation centers, for lower and upper limb therapy. Growing adoption of human exoskeletons in rehabilitation therapy for disabled and elderly patients around the world is expected to fuel the growth of medical exoskeletons in the upcoming years.
An increasing number of people with physical disabilities and subsequent growth in the demand for effective rehabilitation approaches to drive global market growth
Globally, the number of persons with physical disabilities is on the rise, owing to causes such as an aging population, an increase in the frequency of road accidents and severe trauma injuries, and an increase in the prevalence of stroke, among others. The worldwide old population is expected to rise steadily in the following years, from 703 million in 2019 to 1.5 billion by 2050, according to the US Census Bureau. The number of people with impairments is rising as the geriatric population grows, as the elderly are more vulnerable to illnesses like stroke and severe musculoskeletal injuries from falls. The huge increase in the senior population not only means that there will be more potential customers for medical exoskeletons in the future, but it also means that there will be fewer active people to care for the elderly and disabled. As a result, there is a growing demand for efficient rehabilitation methods that include the use of innovative and modern technology and goods all over the world.
Regulatory Challenges for securing approvals for medical applications of exoskeletons in Medical Exoskeletons hamper the market growth
During product testing, the manufacturer's technical design skills and knowledge can make a difference. Exoskeletons designed for healthcare applications must be properly scrutinized because the failure of medical equipment can have life-threatening repercussions. There are currently just a few standards that directly apply to the exoskeleton sector. Only items that have received regulatory approvals can be marketed on the market, and the FDA recognizes ISO standards that are applicable to relevant industries. Although powered lower-limb exoskeletons have advanced significantly, users are still having difficulty handling sloped or slippery surfaces. Because the prototypes can't handle twisting motions yet, users turning while carrying goods may quickly tire out, causing undesirable outcomes such as skin and tissue damage and bone fractures. As a result, regulatory organizations have set in place a stringent licensing process for such devices to ensure that the wearer's safety is not jeopardized by the high-power output of actuators utilized in them.
Increasing insurance coverage for medical exoskeletons in several countries to bring growth opportunities for the global market
Assistive technology is an important element of healthcare. Many rehabilitation institutions in numerous nations rely on assistive devices supplied by government agencies, special agencies, insurance firms, and charity and non-governmental groups. Exoskeleton technology is currently covered by insurance companies in only a few countries. Companies, on the other hand, are working on developing policies and forming strategic partnerships and agreements with a variety of public and commercial insurance providers to cover the costs of medical exoskeleton equipment. Ekso Bionics, for example, is addressing the Centers for Medicare and Medicaid Services as well as third-party insurers, as they are expected to play a key role in the Ekso GT device's long-term commercial adoption.
The global medical exoskeleton market is segmented based on Component, Type, Extremity, Mobility, Structure, and region.
Based on Component, the global medical exoskeleton market is divided into Hardware and Software.
On the basis of Type, the global medical exoskeleton market is bifurcated into Powered Exoskeletons and Passive Exoskeletons.
By Extremity, the global medical exoskeleton market is split into Upper Extremity Medical Exoskeletons, Lower Extremity Medical Exoskeletons, Full Body.
In terms of Mobility, the global medical exoskeleton market is categorized into Mobile Exoskeletons and Stationary Exoskeletons.
By Structure, the global Medical Exoskeleton market is divided into Rigid Exoskeletons and Soft Exoskeleton.
Report Attributes | Report Details |
---|---|
Report Name | Medical Exoskeleton Market |
Market Size in 2024 | USD 1.09 Billion |
Market Forecast in 2034 | USD 7.15 Billion |
Growth Rate | CAGR of 20.7% |
Number of Pages | 199 |
Key Companies Covered | Ekso Bionics (US), ReWalk (Israel), Parker Hannifin (US), Cyberdyne (Japan) and Bionik (Canada), Rex Bionics (UK), B-TEMIA Inc. (Canada), Bioventus (North Carolina), Hocoma AG (a subsidiary of DIH Technologies) (Switzerland), Wearable Robotics SRL (Italy), Gogoa Mobility Robots SL (Spain), ExoAtlet (Luxembourg), Meditouch (Israel), Suit X (US), P&S Mechanics (South Korea), Marsi Bionics (Spain), Rehab Robotics (Hong Kong), Myomo (US), Focal Meditech (Netherlands), Honda Motors (Japan), Watercraft (France), BAMA Teknoloji (Turkey), Medeco Robotics (Hong Kong), Fourier Intelligence (China), TWICE (Switzerland),, and others. |
Segments Covered | By Component, By Type, By Extremity, By Mobility, By Structure, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, The Middle East and Africa (MEA) |
Base Year | 2024 |
Historical Year | 2020 to 2024 |
Forecast Year | 2025 to 2034 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
With a market share of 44.4 percent in 2020, North America is predicted to dominate the industry. The rising senior population, rising demand for self-assist exoskeletons, the high frequency of stroke, and the rising number of spinal cord injuries (SCI) are all pushing the medical exoskeleton market in this region. Due to an increase in the manufacturing of medical exoskeletons for the defense sector, Asia-Pacific is expected to have a high CAGR in the global market. Furthermore, China, Japan, and South Korea are predicted to be the key revenue-generating economies in the emerging world.
The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the medical exoskeleton market on a global and regional basis.
The global medical exoskeleton market is dominated by players like:
The global medical exoskeleton market is segmented as follows;
By Component
By Type
By Extremity
By Mobility
By Structure
By Region
FrequentlyAsked Questions
Leading players in the global medical exoskeleton market include Ekso Bionics (US), ReWalk (Israel), Parker Hannifin (US), Cyberdyne (Japan) and Bionik (Canada), Rex Bionics (UK), B-TEMIA Inc. (Canada), Bioventus (North Carolina), Hocoma AG (a subsidiary of DIH Technologies) (Switzerland), Wearable Robotics SRL (Italy), Gogoa Mobility Robots SL (Spain), ExoAtlet (Luxembourg), Meditouch (Israel), Suit X (US), P&S Mechanics (South Korea), Marsi Bionics (Spain), Rehab Robotics (Hong Kong), Myomo (US), Focal Meditech (Netherlands), Honda Motors (Japan), Watercraft (France), BAMA Teknoloji (Turkey), Medeco Robotics (Hong Kong), Fourier Intelligence (China), TWICE (Switzerland),, among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed